
Written by a model from the transcript; not yet reviewed.
In this episode, the guest discusses breakthroughs in aging research and human rejuvenation, detailing how his Harvard lab and other researchers have successfully reversed aging in mice by delivering OSK genes through domesticated, virus-like capsules. The conversation explores the shifting boundaries of science, moving from speculative theory to active human trials for glaucoma and vision loss, alongside the role of artificial intelligence in compressing decades of drug discovery into months. They also debate lifestyle choices, diets, stress, and the psychological impact of modern technology while emphasizing the importance of momentum and physical vitality.
Rogan and Sinclair speculate on ancient advanced societies and how their knowledge might relate to modern longevity science.
Sinclair outlines the progress in aging research since 2019 and the shift from speculation to clinical trials.
Sinclair describes the viral delivery system, OSK genes, and the eye-based clinical trial for glaucoma.
The episode concludes with reflections on the impact of life extension on society and personal aspirations.
Discussion moves to broader uses, potential for super-soldiers, and the moral implications of extended life.
Discussion of the biological clock, how resetting it can reverse aging and improve cognitive function in mice and potentially humans.
Exploration of growing human hair on mice, potential beauty treatments, and the future of hair transplants.
Joe and David talk about how relationships, stress, and social support influence biological aging.
Joe explains how erectile dysfunction drugs may reduce cancer risk and affect aging through nitric oxide signaling.
The link between GLP‑1 medications and increased risk of non‑arteritic anterior ischemic optic neuropathy is examined.
David discusses how artificial intelligence accelerates data analysis, enabling rapid breakthroughs in aging research.
The potential to regrow limbs using new biology and existing technologies is discussed, with a realistic timeline.
The growing involvement of tech billionaires and large pharma in anti‑aging research is highlighted.
Speculation on mapping and engineering consciousness to create a harmonious, disease‑free society.
Discussion of major pharma companies investing in psychedelic research and the potential therapeutic benefits for addiction and mental health.
Joe explains his advocacy for ibogaine, its therapeutic use, and the challenges of its Schedule I classification.
Exploration of whether the therapeutic benefits of psychedelics can be achieved without the hallucinogenic experience, citing LSD analogs.
Introduction of the engineered LSD analog JRT, its neuroplasticity benefits, and early animal study results.
Longevity Boom Post-2019insight
The guest explains how the 2019 bestselling book Lifespan combined with the pandemic to spark global interest in mortality and health optimization, turning longevity into a cultural phenomenon.
First Human Age Reversal Trialdata
The guest reveals that the first potential human age reversal technology is currently being tested on patients with glaucoma, successfully using engineered gene packages.
Three Yamanaka Genes for Youthinsight
Researchers discovered that leaving out one of the four Yamanaka genes and using just three, OSK, achieves safe cellular age reversal without turning cells back into stem cells.
AI Speeds Up Drug Discoverydata
The guest explains how computational power and AlphaFold proteins allowed AI to complete a two-month analysis that would have otherwise taken over a century.
ED Drugs and Cancer Resistanceinsight
Low-dose Tadalfil and similar medications show potential in protecting against certain cancers, including head and neck cancer, by improving immune response and blocking cholesterol.
The Dopamine Risk Gene Variantdata
The discussion notes that the D4 dopamine receptor seven-repeat variant, associated with novelty seeking and risk-taking, is far more common in populations across the Americas.
Hyperbaric Chambers and Hypoxiainsight
The guest shares an insight from visiting an Israeli hyperbaric chamber study, noting that the decompression phase mimics hypoxia and triggers regenerative biological responses.
“The first potential human age reversal technology is in people right now.”
“We could change that outside little spike and target it to the liver, which we've done, and cured mice of their fatty liver disease as well.”
“The drug that we know when we put it into human cells, it makes them younger, and then they work like they were young again.”
“When you move the hands of the clock, time goes backwards for the body.”
“Alzheimer's patients, I believe, still have memories. They just cannot access them and that one day we can reverse Alzheimer's disease by making the brain young.”
“The other two mechanisms, one showed that Tadalfil is good for exposing the tumor to the immune system. There are certain cells called M D S Cs that protect the tumor from getting attacked.”
“I think the future really does belong to people who can wrangle AI even on their phone.”
“I think it was like $3.8 billion.”
“So they're all in with real capital.”
“You know, which is so crazy that this thing had been around for so long and is a schedule one substance in the United States for no reason whatsoever.”
David Sinclair, AO, PhD, is a longevity scientist, Professor of Genetics at Harvard Medical School, author of the book "Lifespan: Why We Age—and Why We Don't Have To," and host of the "Lifespan" podcast.www.youtube.com/c/davidsinclairpodcast www.simonandschuster.com/books/Lifespan/David-Sinclair/9781501191978 https://lifespan.com https://davidasinclair.com Perplexity: Download the app or ask Perplexity anything at https://pplx.ai/rogan. Visit https://superpower.com/rogan for $20 off your membership. This video is sponsored by BetterHelp. Visit https://BetterHelp.com/JRE Learn more about your ad choices. Visit podcastchoices.com/adchoices
29,109 words · 5 speakers
Page updated · transcript and summary are machine-generated